Scorpius Holdings Becomes a Member of the BioMaP-Consortium

Provides Scorpius opportunities to support biomanufacturing programs focused on the nation’s medical countermeasure programs & more.

Author Image

By: Charlie Sternberg

Associate Editor

Scorpius Holdings Inc., an integrated contract development and manufacturing organization (CDMO), has been accepted into the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium), a part of the National Biopharmaceutical Manufacturing Partnership.   The BioMap-Consortium has a $20 billion funding ceiling, through which it provides growth funding, as well as streamlined access to servicing government-funded manufacturing programs.   The consortium supports the Biomedical...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters